Selonsertib in Adults With Pulmonary Arterial Hypertension
Public ClinicalTrials.gov record NCT02234141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Study identification
- NCT ID
- NCT02234141
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 151 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Selonsertib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2014
- Primary completion
- Mar 31, 2016
- Completion
- Nov 30, 2016
- Last update posted
- Apr 9, 2019
2014 – 2016
United States locations
- U.S. sites
- 24
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama Medical Center | Mobile | Alabama | — | — |
| Advanced Lung Disease Institute | Phoenix | Arizona | — | — |
| Arizona Pulmonary Specialist, Ltd | Phoenix | Arizona | — | — |
| University of Arizona Clinical and Translational Science (CATS) Research Center | Tucson | Arizona | — | — |
| VA Greater Los Angeles Healthcare System | Los Angeles | California | — | — |
| University of California, Davis | Sacramento | California | — | — |
| University of California, San Francisco | San Francisco | California | — | — |
| LA Biomedical Research Institute Harbor-UCLA Medical Center | Torrance | California | — | — |
| University of Colorado Cardiac and Vascular Center, Anschutz Inpatient Pavillion | Aurora | Colorado | — | — |
| The Emory Clinic | Atlanta | Georgia | — | — |
| University of Chicago Medicine | Chicago | Illinois | — | — |
| Boston University Medical Center | Boston | Massachusetts | — | — |
| Tufts Medical Center | Boston | Massachusetts | — | — |
| University of Michigan Health System | Ann Arbor | Michigan | — | — |
| University of Minnesota | Minneapolis | Minnesota | — | — |
| Mayo Clinic | Rochester | Minnesota | — | — |
| Washington University School of Medicine | St Louis | Missouri | — | — |
| Mary M. Parkes Center // University of Rochester Medical Center | Rochester | New York | — | — |
| Cleveland Clinic | Cleveland | Ohio | — | — |
| Martha Morehouse Medical Pavilion | Columbus | Ohio | — | — |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | — | — |
| UPMC Presbyterian Hospital | Pittsburgh | Pennsylvania | — | — |
| UT Southwestern Medical Center | Dallas | Texas | — | — |
| Inova Fairfax Medical Campus | Falls Church | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02234141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 9, 2019 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02234141 live on ClinicalTrials.gov.